Naloxone as mitochondrial phenotype rescuer in a 3D bioprinted LCHADD/VLCADD model
Antonia Degen, Michael J. Ausserlechner, Verena Sturmlehner, Christian Ploner, Sara Tucci, Daniela Karall, Hamed Homaei Rad, Lukas Neumann, Judith Hagenbuchner
Naloxone, a NOX2 inhibitor, largely restored mitochondrial networks and curbed a pro-fibrotic signature in LCHADD/VLCADD patient fibroblasts, and rescued impaired vessel formation in 3D bioprinted vascularized constructs.
bioRxiv · Sep 22, 2026 · PreprintMolecular Biology✦ In-depth digest